NM MPJE flashcards
NM MPJE · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- New Mexico Pharmacy Practice Act
- NMSA Chapter 61, Article 11 is the statute governing pharmacist licensure, pharmacy practice, Board authority, and discipline in New Mexico.
- New Mexico Board of Pharmacy rules
- Board regulations are codified in Title 16, Chapter 19 NMAC and implement the Pharmacy Practice Act, including licensure, dispensing, compounding, and records requirements.
- Board disciplinary authority
- The Board may deny, suspend, revoke, or condition a license or registration, impose civil penalties, and issue cease-and-desist orders for violations of pharmacy law.
- Grounds for Board discipline
- Grounds include fraud or deception, incompetence, unprofessional conduct, impaired practice, criminal conviction affecting practice, and violation of pharmacy statutes or Board rules.
- Pharmacy intern registration
- A pharmacy intern must be registered with the New Mexico Board before performing intern duties and must practice under a pharmacist preceptor who documents internship hours.
- Pharmacy technician registration
- Pharmacy technicians must be registered with the Board and work under pharmacist supervision; certified technician status may require national certification and Board recognition.
- Pharmacy site licensure
- A pharmacy must hold a New Mexico pharmacy license for its location and must notify the Board of ownership, location, or manager changes as required by rule.
- License renewal continuing education
- New Mexico licensees must complete Board-required continuing education each renewal cycle, retain certificates for audit, and renew by the assigned deadline to avoid late fees.
- Schedule II refills
- Federal law prohibits refills on Schedule II prescriptions; a new prescription is required, except emergency oral orders that must be followed by a written prescription within seven days.
- Schedule III-V refill limit
- A prescription for a Schedule III, IV, or V controlled substance may be refilled up to five times within six months of the issue date, unless the prescriber specifies fewer.
- New Mexico PMP reporting
- New Mexico dispensers report controlled substance prescriptions to the state prescription monitoring program, which pharmacists query to identify unsafe or duplicative controlled substance use.
- Controlled substance inventory
- Pharmacies must take an initial inventory and biennial inventories of controlled substances, keep Schedule II records separate, and report theft or significant loss to DEA and the Board.
- Prescription required elements
- A prescription must identify the patient, drug, strength, dosage form, quantity, directions, date, prescriber, and refills; controlled substance prescriptions also require the prescriber's DEA number.
- Prescription transfer limits
- Schedule II prescriptions may not be refilled or transferred for refill; Schedule III-V prescriptions may be transferred between pharmacies with required documentation under federal and state rules.
- Prescription label requirements
- The dispensed label must show pharmacy name and address, prescription number, date, patient name, directions, prescriber, drug name and strength, quantity, and beyond-use or expiration date.
- Offer to counsel
- A pharmacist must offer counseling on each new prescription and when needed, covering directions, side effects, interactions, storage, and adherence; counseling may be declined and documented.
- Pharmaceutical care
- Pharmaceutical care is the pharmacist's responsible provision of drug therapy to achieve definite outcomes that improve a patient's quality of life while identifying and resolving medication problems.
- Patient counseling privacy
- Counseling should occur in an area that protects patient confidentiality, and protected health information may be shared only as permitted by HIPAA and state privacy law.
- Medication profile review
- Before dispensing, the pharmacist reviews the patient profile for allergies, duplicative therapy, interactions, dose appropriateness, and adherence, and documents clinically significant interventions.
- Adverse event reporting
- Pharmacists should document and report serious adverse drug events and medication errors through internal quality processes and required federal or state reporting systems.
- Collaborative practice agreement
- A written agreement between a pharmacist and prescriber defines delegated drug therapy management, documentation, communication, and patient monitoring responsibilities within state law.
- Pharmacist vaccine administration
- New Mexico pharmacists may administer vaccines under Board rules and protocols, maintain immunization records, and report doses to the state immunization registry as required.
- Pharmacist clinician authority
- New Mexico recognizes a pharmacist clinician credential for advanced practice; prescriptive authority depends on Board rules, collaborative agreements, and the pharmacist's scope of practice.
- Drug distribution licensing
- Wholesalers, manufacturers, and distributors of prescription drugs must be appropriately licensed and comply with federal and New Mexico storage, recordkeeping, and tracing requirements.
- USP 795 nonsterile compounding
- USP General Chapter 795 sets standards for nonsterile compounding, including facility, equipment, master formulation records, compounding records, and assignment of beyond-use dates.
- USP 797 sterile compounding
- USP General Chapter 797 sets requirements for sterile compounding, including cleanroom classifications, environmental monitoring, personnel training, gowning, and beyond-use dating.
- USP 800 hazardous drugs
- USP General Chapter 800 requires containment strategies for hazardous drugs, including engineering controls, personal protective equipment, deactivation, cleaning, and waste handling.
- Compounding beyond-use date
- A beyond-use date is the maximum date a compounded preparation may be used, based on USP standards, ingredient stability, preservative, storage, and container system.
- DSCSA dispenser duties
- Under the Drug Supply Chain Security Act, dispensers must receive and retain transaction information, verify suspect product, quarantine illegitimate product, and respond to recalls.
- HIPAA minimum necessary
- HIPAA requires covered pharmacies to limit protected health information use and disclosure to the minimum necessary for the purpose, with safeguards and breach notification.
- Controlled substance recordkeeping
- Controlled substance prescriptions and inventories must be maintained and readily retrievable for inspection; Schedule II records are kept separate from other prescription records.
- Pharmacy inspection authority
- Board inspectors and DEA investigators may enter and inspect licensed pharmacy premises and required records to determine compliance with pharmacy and controlled substance laws.